The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CTX-009 (ABL001), a bispecific antibody targeting DLL4 and VEGF A, in combination with paclitaxel in patients with advanced biliary tract cancer (BTC): A phase 2 study.
 
Do-Youn Oh
Consulting or Advisory Role - Arcus Biosciences; ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; IQVIA; Merck Serono; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; Celgene; MediRama; Merck Serono; SERVIER
Research Funding - ABL Bio; Celgene; Eutilex; medpacto; SERVIER
 
Jin Won Kim
Consulting or Advisory Role - AstraZeneca; BeiGene Beijing; BeiGene Beijing; BeyondBIO; Bristol-Myers Squibb/Celgene; Eisai; GC Cell; MSD; Ono Pharmaceutical; Roche; Sanofi; Servier; TCUBEit
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech
 
Jeesun Yoon
No Relationships to Disclose
 
Tae-Yong Kim
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Young Suk Park
No Relationships to Disclose
 
Jeeyun Lee
Consulting or Advisory Role - Mirati Therapeutics; Oncologie
Research Funding - AstraZeneca; Merck Sharp & Dohme
 
Ji-Won Kim
No Relationships to Disclose
 
Keun-Wook Lee
Honoraria - Boryung; JW Pharmaceutical; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Metafines; MSD; Ono Pharmaceutical; Sanofi/Aventis; Vifor Pharma
Research Funding - ABL Bio (Inst); ALX Oncology (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); GC Pharma (Inst); Genome & Company (Inst); Ildong Pharmaceutical (Inst); InventisBio (Inst); Leap Therapeutics (Inst); LSK BioPharma (Inst); Macrogenics (Inst); MedPacto (Inst); Merck KGaA (Inst); MSD (Inst); Oncologie (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Trishula Therapeutics (Inst); Y-BIOLOGICS (Inst); Zymeworks (Inst)
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Changhoon Yoo
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD Oncology; SERVIER
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme; Novartis
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER
 
BokJin Hyun
Employment - Handok
Leadership - Handok
Stock and Other Ownership Interests - Handok
Travel, Accommodations, Expenses - Handok
 
HyunJoo Son
Employment - Handok
Stock and Other Ownership Interests - Handok
Travel, Accommodations, Expenses - Handok
 
SunYoung Kim
Employment - Handok
Travel, Accommodations, Expenses - Handok
 
SangMi Lee
Employment - ABL Bio
Stock and Other Ownership Interests - ABL Bio
Travel, Accommodations, Expenses - ABL Bio
 
Jooyeon Park
Employment - ABL Bio
Travel, Accommodations, Expenses - ABL Bio
 
Eunsin Ha
Employment - ABL Bio
Stock and Other Ownership Interests - ABL Bio
Travel, Accommodations, Expenses - ABL Bio